Codar GF and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Codar GF and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: codeine / guaifenesin
Brand name: Allfen CD, Cheracol with Codeine, Cheratussin AC, Codar GF, Duraganidin NR, Guaiatussin AC, Iophen-C NR, Mar-cof CG, M-Clear, Mytussin AC, Relcof C, Guaifenesin AC Liquid, Iophen C-NR, Mar-cof CG, Ninjacof-XG, Virtussin A/C
Synonyms: n.a.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Codar GF-Insulin degludec
- Codar GF-Insulin Degludec (U-100) Prefilled Pens
- Codar GF-Insulin Degludec (U-100) Vials
- Codar GF-Insulin Degludec (U-200) Prefilled Pens
- Codar GF-Insulin degludec and liraglutide
- Codar GF-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Codeine
- Insulin aspart, recombinant Subcutaneous-Codeine and Chlorpheniramine
- Insulin aspart, recombinant Subcutaneous-Codeine and Chlorpheniramine ER Tablets
- Insulin aspart, recombinant Subcutaneous-Codeine and Chlorpheniramine Extended-Release Suspension
- Insulin aspart, recombinant Subcutaneous-Codeine and Chlorpheniramine Extended-Release Tablets
- Insulin aspart, recombinant Subcutaneous-Codeine and Chlorpheniramine Liquid